AnnJi Pharmaceutical News
Dedicated to New Drug Development in Dermatology & Neurology
AnnJi to Attend BIO Asia–Taiwan 2022 Company Presentation Session and BIO One-on-One PartneringTM
AnnJi will be attending BIO Asia–Taiwan 2022, July 27-31, to meet with potential pharmaceutical partners and investors regarding AnnJi’s programs in dermatology and neurology. Dr. K. Karen Lin, the Director of Business Development, is going to present company’s clinical profiles on site at 16:15, July 27 (https://bioasiataiwan.com/en/program/detail/46).
AnnJi welcome an opportunity to meet with you through BIO One-on-One PartneringTM platform (https://bioasiataiwan.com/en/partner/detail/1) for collaborative discussions.